oxonic acid has been researched along with Sarcoma 180 in 2 studies
Oxonic Acid: Antagonist of urate oxidase.
Sarcoma 180: An experimental sarcoma of mice.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, Y | 1 |
| Ishibiki, Y | 1 |
| Kawai, K | 1 |
| Sasaki, M | 1 |
| Matsuda, M | 1 |
| Watanabe, T | 1 |
| Shirasaka, T | 1 |
| Kamano, T | 2 |
| Yurimoto, S | 1 |
| Miyakawa, A | 1 |
| Okuzawa, A | 1 |
| Sakamoto, S | 1 |
| Sakamoto, K | 1 |
| Hosoda, S | 1 |
2 other studies available for oxonic acid and Sarcoma 180
| Article | Year |
|---|---|
Effect of combination of TS-1 and low-dose cisplatin on sarcoma-180 mouse sarcoma.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Area Under | 2003 |
Enhancement of the anti-tumor activity of S-1 by low-dose cisplatin in mice bearing the sarcoma-180 model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Cisplatin; Drug Combinations; | 2005 |